Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive β-blockers

Gastroenterology

Volumn 121, Issue 4, 2001, Pages 908-914

  García Pagán, Juan Carlos ^a,j   Villanueva, Candido ^b   Vila, Maria Carme ^c   Albillos, Agustin ^d   Genescà, Joan ^e   Ruiz del Arbol, Luis ^d   Planas, Ramón ^f   Rodriguez, Manuel ^g   Calleja, Jose Luis ⁱ   González, Antonio ^e   Solà, Ricard ^c   Balanzó, Joaquim ^b   Bosch, Jaume ^a,j   Escorsell, Angels ^j   Moitinho, Eduardo ^j   Llach, Eduardo ^j   Rodés, Joan ^j   Mióana, Josep ^k   Soriano, German ^k   Marquez, Judith ^c   Gimenez, Maria Dolors ^c   Domper, Francisco ^h   Martinez, Jose Luis ^h   Lopez Talavera, Juan Carlos ^l   Esteban, Rafael ^l   Gonzalez, Mónica ^m   Urman, Jesus ^m   Serradilla, Regina ^m   Morillas, Rosa Maria ^f   Boix, Jaume ^f   Sotorrío, Nieves ^g   Rodrigo, Luis ^g   De la Peña, Joaquin ⁿ   Pons, Fernando ⁿ   Bañares, Rafael ^o   Piñar, Angel ^p   Jimenez, Manuel ^p   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b Hospital Sant Pau   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁱ Hospital Clinic ^*

^j HOSPITAL CLÍNIC   (Spain)

^k HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁿ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^o HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^p HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE MONONITRATE;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; ENDOSCOPY; ESOPHAGUS VARICES; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL;

EID: 0034792003     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.27993     Document Type: Article

References (28)

1. The treatment of portal hypertension: A meta-analytic review
2. Pharmacological treatment of portal hypertension: An evidence-based approach
3. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials
4. Long-term haemodynamic effects of isosorbide-5-mononitrate in patients with cirrhosis and portal hypertension
5. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis
6. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis
7. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices
8. Portal hypertension and variceal bleeding: An AASLD single topic symposium
9. Developing consensus in portal hypertension
10. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function
11. Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Pharmacokinetic-hemodynamic interactions
12. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis
13. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: Effects of pharmacological therapy
14. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis
15. Nadolol and isosorbide 5-mononitrate for preventing bleeding in cirrhotics with ascites
16. Band ligation versus propranotol or isosorbide mononitrate in the primary prophylaxis of variceal haemorrhage: Preliminary results of a randomised controlled trial
17. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis
18. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study
19. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
20. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop
21. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices
22. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: Preliminary report of a randomized controlled trial
23. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices
24. Evaluation of endoscopic variceal ligation in prophylactic therapy for breeding of oesophageal varices: A prospective, controlled trial compared with endoscopic injection sclerotherapy
25. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: A prospective, randomized trial
26. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding
27. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices
28. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding